C O M M U N I C A T I O N S
Scheme 2 a
nitromethane under catalytic double activation (CDAM), in which
both R,â-unsaturated carbonyl acceptors and nitromethane can
be effectively activated by catalytic amounts of chiral Lewis acids
and amine catalysts. For this purpose, the high tolerance of the
R,R-DBFOX/Ph aqua complex catalyst derived from nickel(II)
perchlorate hexahydrate toward amine bases as well as an effective
chirality induction was essential. Other related reactions along this
line are in progress in our group.
Supporting Information Available: Experimental procedure and
spectral data of all new compounds (PDF). This material is available
References
(1) Michael additions of malonates: (a) End, N.; Macko, L.; Zehnder, M.;
Pfaltz, A. Chem. Eur. J. 1988, 4, 818-824. Nitro-Mannich reactions: (b)
Nishiwaki, N.; Knudsen, K. R.; Gothelf, K. V.; Jørgensen, K. A. Angew.
Chem., Int. Ed. 2001, 40, 2992-2995. Nitro aldol reactions: (c) Trost,
B. M.; Yeh, V. S. C. Angew Chem., Int. Ed. 2002, 41, 861-863. (d)
Shibasaki, M.; Sasai, H.; Arai, T. Angew Chem., Int. Ed. Engl. 1997, 36,
1236-1256. Thiol conjugate additions: (e) Hiemstra, H.; Wynberg, H.
J. Am. Chem. Soc. 1981, 103, 417-430.
(2) (a) Kanemasa, S.; Oderaotoshi, Y.; Yamamoto, H.; Tanaka, J.; Wada, E.
J. Org. Chem. 1997, 62, 6454-6455. (b) Kanemasa, S.; Oderaotoshi, Y.;
Tanaka, J.; Wada, E. Tetrahedron Lett. 1998, 39, 7521-7524.
(3) (a) Kanemasa, S.; Oderaotoshi,; Tanaka, J.; Wada, E. J. Am. Chem. Soc.
1998, 120, 12355-12356. (b) Kanemasa, S.; Kanai, T. J. Am. Chem. Soc.
2000, 122, 10710-10711.
(4) (a) Kanemasa, S.; Oderaotoshi, Y.; Sakaguchi, S.; Yamamoto, H.; Tanaka,
J.; Wada, E.; Curran, D. P. J. Am. Chem. Soc. 1998, 120, 3074-3088.
(b) Kanemasa, S.; Oderaotoshi. Y. J. Synth. Org. Chem. Jpn. 1998, 368-
376.
a a: A and TMP (10 mol % each) in MeNO2/THF (1:1 v/v).
Scheme 3 a
(5) Kanemasa, S.; Oderaotoshi, Y.; Wada, E. J. Am. Chem. Soc. 1999, 121,
8675-8676.
(6) For enantioselective conjugate additions of nitroalkanes, see: chiral crown
catalysis: (a) Bako´, P.; Szo¨llo˜sy, AÄ .; Bombicz, P.; To˜ke, L. Synlett 1997,
291-292. (b) Bako´, P.; Kiss, T.; To˜ke, L. Tetrahedron Lett. 1997, 38,
7259-7262. (c) Bako´, P.; Nova´k, T.; Luda´nyi, K.; Pete, B.; To˜ke, L.;
Keglevich, G. Tetrahedron: Asymmetry 1999, 10, 2373-2380. Chiral
alkaloid catalysis: (d) Matsumoto, K.; Uchida, T. Chem. Lett. 1981, 1673-
1676. (e) Sera, A.; Takagi, K.; Katayama, H.; Yamada, H.; Matsumoto,
K. J. Org. Chem. 1988, 53, 1157-1161. Chiral phase-transfer catalysis:
(f) Colonna, S.; Hiemstra, H.; Wynberg, H. J. Chem. Soc., Chem. Commun.
1978, 238-239. (g) Colonna, S.; Re, A. J. Chem. Soc., Perkin Trans. 1
1981, 547-552. Rubidium prolinate catalysis: (h) Yamaguchi, M.;
Shiraishi, T.; Igarashi, Y.; Hirama, M. Tetrahedron. Lett. 1994, 35,
8233-8236. (i) Yamaguchi, M.; Igarashi, Y.; Reddy, R. S.; Shiraishi, T.;
Hirama, M. Tetrahedron 1997, 53, 11223. (j) Yamaguchi, M.; Shiraishi,
T.; Hirama, M. J. Org. Chem. 1996, 61, 3520-3530. Proline catalysis:
(k) Hanessian, S.; Pham, V. Org. Lett. 2000, 2, 2975-2978. Prolinol‚
Ni(II) complex or diamine‚Co(II) complex catalysis: (l) Botteghi, C.;
Paganelli, S.; Schionato, A.; Boga, C.; Fava, A. J. Mol. Cat. 1991, 66,
7-21. LaK3tris(R-binaphthoxide) catalysis: (m) Funabashi, K.; Saida, Y.;
Kanai, M.; Arai, T.; Sasai, H.; Shibasaki, M. Tetrahedron Lett. 1998, 39,
7557-7558.
a a: R,R-DBFOX/Ph - Ni(ClO4)2‚6H2O (10/10 mol %), TMP (10 mol
%), MeNO2/THF (1:1 v/v, 0.1 M), -20 °C, 168 h, 91%. b: H2 Raney Ni,
EtOH/CH2Cl2 (3:2 v/v (0.06 M), 1 atm, rt, 96 h. c: (Boc)2O and 4-DMAP
(2 equiv each), Et3N (1 equiv), rt, 12 h.
Finally, Michael additions of nitromethane with 1-(2-alkenoyl)-
3,5-dimethylpyrazoles (1a-n) having a variety of â-substituents
were found to take place smoothly under the standard conditions
at -20 °C to produce the Michael adducts 2a-n (Scheme 2).
Enantioselectivities up to 98% ee were observed. Acceptor sub-
strates 1a-h with methyl and primary to tertiary alkyl substituents
could be applied successfully, although acceptor 1h with a bulky
tert-butyl substituent is much less reactive. Other â-substituents
such as 1-alkenyl, ester, aryl, heteroaryl moieties work effectively.
Synthetic potential of this new methodology of nitromethane
conjugate additions under CDAM conditions could be demonstrated
successfully in the effective and short step synthesis of (R)-(-)-
rolipram (5o)13 known as an antidepressant and phosphodiesterase
inhibitor (Scheme 3). The desired starting substrate 1o was
synthesized by Wittig-Horner olefination of the substituted benz-
aldehyde, followed by transformation to the pyrazole amide in two
steps. The optical yield of the Michael adduct 2o was determined
to be 98% ee after its reductive conversion to (R)-rolipram 5o
followed by acylation to the N-Boc pyrrolidinone derivative 6o.
The absolute configuration of 5o was determined on the basis of
the reported optical rotation,13,14 indicating that the Re-faces of 1o
have been involved in the carbon-carbon bond-formation step.
In conclusion, the authors have presented a new synthetic
methodology for the enantioselective Michael addition reaction of
(7) Perlmutter, P. Conjugate Addition Reactions in Organic Synthesis;
Pergamon: Oxford, 1992.
(8) The addition reaction in nitromethane/THF (1:1 vol/vol) in the presence
of A and TMP (10 mol % each) is called “standard conditions” hereafter.
(9) One advantage in the use of THF as cosolvent is that the preparation of
catalyst A from the ligand and Ni(ClO4)2‚6H2O can be completed in a
few minutes at room temperature.4a
(10) The R,R-DBFOX/Ph complex derived from Co(ClO4)2‚6H2O showed a
little higher selectivity, but a lower activity (rt, 144 h, 2a: 36%, 86%
ee).
(11) Other R,R-DBFOX/Ph complex catalysts derived from the following salts
did not show any catalytic activity: Zn(ClO4)2‚6H2O, Cu(ClO4)2‚6H2O,
Mg(ClO4)2‚6H2O, Zn(OTf)2, Cu(OTf)2, and Mg(OTf)2.
(12) See Supporting Information.
(13) (a) Mulzer, J.; Zuhse, R.; Schmiechen, R. Angew. Chem., Int. Ed. 1992,
31, 870-872. (b) Meyers, A. I.; Snyder, L. J. Org. Chem. 1993, 58, 36-
42. (c) Baures, P. W.; Eggleston, D. S.; Erhard, K. F.; Cieslinski, L. B.;
Torphy, T. J.; Christensen, S. B. J. Med. Chem. 1993, 36, 3274-3277.
(d) Braun, M.; Opdenbusch, K.; Unger, C. Synlett 1995, 1174-1176. (e)
Diaz, A.; Siro, J. G.; Granc´ıa-Nav´ıo, J. L.; Vaquero, J. J.; Alvarez-Builla,
J. Synthesis 1997, 559. (f) Honda, T.; Ishikawa, F.; Kanai, K.; Sato, S.;
Kato. D.; Tominaga, H. Heterocycles 1996, 42, 109. (g) Anada, M.; Mita,
O.; Watanabe, H.; Kitagaki, S.; Hashimoto, S. Synlett 1999, 1775-1777.
(14) R)-(-)-Rolipram (5o) was purified by crystallization from AcOEt/hexane
(>99% ee). [R]D -33.9° (c 1.09, MeOH) (Lit.14 [R]D -31.1° (c 1.08,
MeOH)).
JA027313+
9
J. AM. CHEM. SOC. VOL. 124, NO. 45, 2002 13395